Dow Dull Except for...
Health Care: Drugs
DARA Biosciences Inc. (DARA: NASDAQ)
$0.70 0.00 | 0.33%
05/20/13 - 02:30 PM ET
Company Income Statement
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Sales | 53.63K | 0.00 | 0.00 | 0.00 |
| Cost of Sales | 6.07K | 0.00 | -145.30K | -157.17K |
| Gross Operating Profit | 47.56K | 0.00 | 145.30K | 157.17K |
| Selling, General, and Administrative Expenses | 6.27M | 4.13M | 3.14M | 2.85M |
| Research & Development | 2.73M | 2.63M | 3.34M | 1.89M |
| Operating Income before D & A (EBITDA) | -8.96M | -6.76M | -6.34M | -4.58M |
| Depreciation & Amortization | 677.18K | 139.39K | 145.30K | 157.17K |
| Interest Income | 0.00 | 91.71K | 0.00 | 0.00 |
| Other Income - Net | 608.60K | -1.51K | 496.63K | 1.21M |
| Special Income / Charges | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | -9.03M | -6.81M | -5.99M | -3.52M |
| Interest Expense | 11.72K | 0.00 | 3.77K | 39.43K |
| Pre-Tax Income | -9.04M | -6.81M | -5.99M | -3.56M |
| Income Taxes | -1.30M | -194.44K | 0.00 | 0.00 |
| Minority Interest | -429.34K | -306.66K | -339.49K | -218.34K |
| Net Income From Continuing Operations | -7.74M | -6.17M | -5.65M | -3.34M |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | -7.74M | -6.17M | -5.65M | -3.34M |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | -7.31M | -6.17M | -5.65M | -3.34M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-7.74M | -6.17M | -5.65M | -3.34M |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | -7.74M | -6.17M | -5.65M | -3.34M |
| Basic EPS from Continuing Ops. | -0.60 | -1.20 | -1.80 | -1.60 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | -0.60 | -1.20 | -1.80 | -1.60 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | -0.60 | -1.20 | -1.80 | -1.60 |
| Basic Normalized Net Income/Share | -0.60 | -1.20 | -1.80 | -1.60 |
| EPS fr Continuing Ops. | -0.60 | -1.20 | -1.80 | -1.60 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | -0.60 | -1.20 | -1.80 | -1.60 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | -0.60 | -1.20 | -1.80 | -1.60 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-0.60 | -1.20 | -1.80 | -1.60 |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with DARA
- Portfolio NameUser Type
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- UserStan/Gino
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- UserIf you can't join them,whup...
- Usergarym
Latest DARA Headlines from TheStreet
- 5 Stocks Under $10 Poised to Pop 01.24.13 | 12:01 pm
- 5 Stocks Under $10 Set to Soar Higher 09.27.12 | 01:09 pm
- 3 Stocks Under $5 Moving Higher 09.13.12 | 02:09 pm
- 5 Stocks Under $10 Set to Soar Higher 08.30.12 | 12:08 pm
- Report From Results Of A Successful Phase II Study For DARA's KRN5500 At ADEPT 03.29.11 | 08:03 am
- DARA BioSciences Filing Shelf Registration Statement To Replace Expiring Registration Statement 03.25.11 | 04:03 pm
- DARA BioSciences Is Selected By MDB Capital Group As A 2011 "Best & Brightest-Company To Watch" 02.23.11 | 08:02 am
- DARA BioSciences To Present At The Wall Street Analyst Forum 22nd Annual Analyst Conference 02.17.11 | 09:02 am
- Agile Companies Like DARA BioSciences Advance Research For New Diabetes Medicines As Incidence Of Disease Relentlessly Increases 02.15.11 | 09:02 am
- Study Results For DARA Biosciences' Lead Drug For Neuropathic Pain, KRN5500, Selected For Presentation By The International Conference On Accelerating The Development Of Enhanced Pain Treatments ("ADEPT") 02.01.11 | 08:02 am
Press Releases for DARA
- DARA BioSciences Regains Compliance With NASDAQ $1.00 Minimum Bid Price Rule - Business Wire 02.14.13 | 08:02 am
- DARA BioSciences To Present At 15th Annual BIO CEO & Investor Conference - Business Wire 02.11.13 | 08:02 am
- DARA BioSciences To Present At The 6th Annual OneMedForum Conference - Business Wire 01.08.13 | 08:01 am
- DARA BioSciences To Raise $2.8 Million Pursuant To Securities Purchase Agreement - Business Wire 12.31.12 | 08:12 am
- DARA BioSciences Announces Submission Of KRN5500 To FDA For Orphan Designation - Business Wire 11.29.12 | 08:11 am
- Dara Biosciences Reports Financial Results For The Third Quarter 2012 - Business Wire 11.14.12 | 05:11 pm
- DARA BioSciences Will Present At NYSSA Investing In Life Sciences Conference, November 29 - Business Wire 11.12.12 | 09:11 am
- DARA BioSciences Will Present At Singular Research Conference November 1 - Business Wire 10.29.12 | 03:10 pm
- Soltamox, Liquid Version Of Tamoxifen Citrate (Photo: Business Wire) - Business Wire 10.22.12 | 06:10 am
- Soltamox, Liquid Version Of Tamoxifen Citrate (Photo: Business Wire) - Business Wire 10.22.12 | 06:10 am
Partner Headlines for DARA
- Benzinga's Small Cap Movers for Friday November 16, 2012 - Benzinga 11.18.12 | 11:11 am
- Benzinga's Microcap Movers for Friday September 14, 2012 - Benzinga 09.15.12 | 08:09 pm
- DARA Biosciences Inks Deal - Analyst Blog - NASDAQ 08.23.12 | 10:08 pm
- DARA Biosciences Inks Deal - Analyst Blog - Zacks 08.23.12 | 07:08 pm
- DARA Bio Starting To Look Interesting - Analyst Blog - Zacks 05.08.12 | 10:05 am
- Morning Market Losers - Benzinga 04.09.12 | 09:04 am
- Morning Market Movers - Benzinga 03.26.12 | 09:03 am
- DARA BioSciences Spiking Higher after Positive Phase I Results - Benzinga 06.28.11 | 09:06 am
- Life Sciences Companies Raise Record Amounts of Capital - Seeking Alpha 12.31.10 | 04:12 pm
- News Summary - Benzinga 12.29.10 | 09:12 am
